A great read on the ongoing work in this space.
https://www.cancertherapyadvisor.com/general-oncology/cancer-vaccine-research-checkpoint-inhibitors-use/article/831732/
From the company's announcement dated 27/07/18 below....
https://hotcopper.com.au/threads/ann-successful-in-vivo-results-peptide-vaccine-t-cell-expansion.4325318/
"The peptide vaccine program continues to progress in the context of multiple different antigens (cargoes) and disease indications towards its ultimate read-out of complementarity to existing therapies in each of these indications to demonstrate improved treatment efficacy."
"complementarity to existing therapies"
Tony
Ann: First Competitive Read Out - Peptide Vaccine, page-14
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $415.6K | 3.255M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 112056 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 127118 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |